If you could vote on Brexit now which option would you choose?

Bharat Biotech, government cash and partners in hand, aims for 700M COVID-19 shots per year

With COVID-19 cases mounting, India has equipped local drugmaker Bharat Biotech with government cash to rapidly scale up its vaccine output this year. Bharat plans to upgrade at two plants to boost production of its COVID-19 vaccine Covaxin to nearly 700 million doses a year, Mint reports. The lift comes after the Indian government awarded the drugmaker nearly $200 million to upgrade capacity amid a sharp rise in local coronavirus infections. Bharat has more help on the way, too, thanks to a trio of government-funded manufacturing partners that will come online later this year. The country has tasked Bharat with doubling its vaccine output by June and producing around 100 million doses per month by September.

FiercePharma - April 20, 2021

View the full story here: https://www.fiercepharma.com/manufacturing/bharat-biotech-government-cash-hand-aims-for-700-million-covid-19-vaccines-per-year